Your search for dabigatran returned 115 results
Drugs in the Pipeline
Dabigatran Comparable to Warfarin in DVT/PE Trial
Boehringer Ingelheim announced results from the RE-COVER II study evaluating dabigatran compared to warfarin in patients diagnosed with acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
News
Factors Associated with Greater Dabigatran Adherence
Appropriate patient selection and pharmacist-led monitoring were linked to greater adherence to dabigatran among patients with atrial fibrillation at Veterans Health Administration sites, according to a recent study published in JAMA.
ACC.17
Stroke, Major Bleeding Risk Low with Dabigatran Etexilate
The data represents ~3,000 patients who had received the study drug in Phase 3 of GLORIA-AF with up to 2 years follow-up.
American College of Cardiology 2011
Dabigatran Etexilate vs. Warfarin in Different Types of Atrial Fibrillation
A subgroup analysis from the RE-LY trial has demonstrated that in patients with atrial fibrillation (AF), twice-daily dabigatran etexilate has better efficacy and lower rates of major bleeding when compared with warfarin, as reported at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.
Drug News
Women More Often Treated with Low-Dose Dabigatran
Despite trend toward lower stroke risk with high dose
News
Dabigatran Combined with Certain Statins May Up Hemorrhage Risk in A-Fib Patients
Combining dabigatran with certain statin medications could raise the odds for major hemorrhage in patients with atrial fibrillation, according to a study published online in CMAJ, the journal of the Canadian Medical Association.
News
Stimulated Reporting Accounts for High Dabigatran Bleeding
The increased number of post-marketing reports of bleeding associated with use of dabigatran seems to be an example of stimulated reporting and may not represent an increased bleeding risk.
News
Oral Anticoagulants Compared for Gastrointestinal Safety
The researchers found the risk of GI bleeding was lower for apixaban versus dabigatran or rivaroxaban.
Drug News
Dabigatran vs.Warfarin: New Findings Conflict with FDA Analysis
Dabigatran is associated with higher risks of major bleeding and gastrointestinal bleeding compared with warfarin, but patients taking dabigatran also have a reduced risk of intracranial bleeding compared with those taking warfarin, according to new research.
